Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The in vitro activity of acyclovir and related compounds against cytomegalovirus infections.

× No keyword cloud information.

11 in total

1. Treatment of experimental cytomegalovirus infections with acyclovir.

Authors: C A Bruggeman; W Engels; J Endert
Journal: Arch Virol Date: 1987 Impact factor: 2.574

2. Prevention of cytomegalovirus infection by valaciclovir after allogeneic bone marrow transplantation from an unrelated donor.

Authors: Takehiko Mori; Yoshinobu Aisa; Takayuki Shimizu; Tomonori Nakazato; Rie Yamazaki; Yasuo Ikeda; Shinichiro Okamoto
Journal: Int J Hematol Date: 2006-04 Impact factor: 2.490

3. Acyclovir.

Authors: M C Timbury
Journal: Br Med J (Clin Res Ed) Date: 1982-10-30

4. Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses.

Authors: V R Freitas; D F Smee; M Chernow; R Boehme; T R Matthews
Journal: Antimicrob Agents Chemother Date: 1985-08 Impact factor: 5.191

Review 5. Acquisition of cytomegalovirus infection: an update.

Authors: B A Forbes
Journal: Clin Microbiol Rev Date: 1989-04 Impact factor: 26.132

6. Therapeutic effect of acyclovir (ZoviraxTM) on the pathogenesis of chronic murine cytomegalovirus infection in the immunodeficient nude mouse.

Authors: P Carthew
Journal: Br J Exp Pathol Date: 1982-12

Review 7. Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors: D M Richards; A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal: Drugs Date: 1983-11 Impact factor: 9.546

8. Synergistic antiviral activity of acyclovir and interferon on human cytomegalovirus.

Authors: C A Smith; B Wigdahl; F Rapp
Journal: Antimicrob Agents Chemother Date: 1983-09 Impact factor: 5.191

Review 9. Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors: J J O'Brien; D M Campoli-Richards
Journal: Drugs Date: 1989-03 Impact factor: 9.546

10. Acyclovir Therapy Reduces the CD4+ T Cell Response against the Immunodominant pp65 Protein from Cytomegalovirus in Immune Competent Individuals.

Authors: Annette Pachnio; Jusnara Begum; Ashini Fox; Paul Moss
Journal: PLoS One Date: 2015-04-29 Impact factor: 3.240